SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-23-079647
Filing Date
2023-07-10
Accepted
2023-07-10 16:01:10
Documents
2
Group Members
CITADEL ADVISORS HOLDINGS LPCITADEL GP LLCCITADEL SECURITIES GP LLCCITADEL SECURITIES GROUP LPCITADEL SECURITIES LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2320955-1_sc13g.htm SC 13G 138106
2 EXHIBIT 99.1 tm2320955d1_ex99-1.htm EX-99.1 10157
  Complete submission text file 0001104659-23-079647.txt   150085
Mailing Address SOUTHEAST FINANCIAL CENTER 200 S. BISCAYNE BLVD., SUITE 3300 MIAMI FL 33131
Business Address SOUTHEAST FINANCIAL CENTER 200 S. BISCAYNE BLVD., SUITE 3300 MIAMI FL 33131 305-929-6851
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Subject) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92596 | Film No.: 231079736
SIC: 2834 Pharmaceutical Preparations